Medical University of Vienna: all 1,105 studies
Page 12 of 12. Open to participants first (182), then studies with results posted, then the rest; newest registration first within each.
- Bortezomib, Rituximab and Dexamethasone (BORID) for Relapsed/Refractory Mantle Cell LymphomaStatus unknownNCT00261612Phase 2
- Vaginal Progesterone in the Treatment of Cervical Dysplasia Grade I and IICompletedNCT00247169Phase 2
- The Vienna Prograf and Endothelial Progenitor Cell StudyCompletedNCT00182559Phase 4
- Omega-3-Polyunsaturated Fatty-Acids (N3-Pufa) In Patients With Severe Chronic Heart FailureCompletedNCT00149409Phase 2/3
- Treatment of Hepatocellular Carcinoma: Long-Acting Somatostatin Plus Percutaneous Ethanol Instillation (PEI) Versus Long-Acting Somatostatin AloneStatus unknownNCT00121914Phase 3